[Time-dependent and dose-dependent regulation of human progesterone receptor isoforms A and B in uterine endometrial carcinoma by human insulin-like growth factor-I]

Zhonghua Fu Chan Ke Za Zhi. 2002 Mar;37(3):164-7.
[Article in Chinese]

Abstract

Objective: We study the regulation of human progesterone receptor isoforms A and B in uterine endometrial carcinoma cell line by different concentration of human insulin-like growth factor-I (IGF-I) for different time, to investigate the roles of IGF-I and progesterone receptor isoforms in uterine endometrial carcinoma.

Methods: The uterine endometrial adenocarcinoma cell line HEC-IB was cultured in vitro and the breast cancer cell line MCF-7 was used as control. Western blot was applied to examine the changes of the two isoforms by different concentration IGF-I for different time.

Results: (1) In HEC-IB cell line, 10 ng/ml IGF-I made hPRB up-regulated in the first 24 h. But according to lager concentration and longer time, human progesterone receptor (hPR) B became down-regulated, which were significant at 20 ng/ml IGF-I for 72 h and 40 ng/ml IGF-I for 48 - 72 h. The change of hPRA was like hPRB. (2) In MCF-7 cell line, 10 ng/ml and 40 ng/ml IGF-I made hPRA and hPRB significantly up-regulated in 24, 48, 72 h. Twenty ng/ml IGF-I made hPRB up-regulated also in the first 24 h. But in 48 h and 72 h, down-regulation of hPRB was detected. Twenty ng/ml IGF-I made hPRA down-regulated in 24, 48, 72 h.

Conclusions: (1) The regulation of IGF-I to hPR isoforms has cell-type specific and dose-dependent and time-dependent. (2) In HEC-IB cell line, 10 ng/ml IGF-I made hPRB significantly up-regulated in 24 h. But following exposure to IGF-I at larger concentration and longer time, hPRB became down-regulated. The change of hPRA is like hPRB.

Publication types

  • English Abstract

MeSH terms

  • Blotting, Western
  • Breast Neoplasms / pathology
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Endometrial Neoplasms / metabolism*
  • Endometrial Neoplasms / pathology
  • Female
  • Gene Expression Regulation / drug effects*
  • Humans
  • Insulin-Like Growth Factor I / pharmacology*
  • Organ Specificity / physiology
  • Receptors, Progesterone / genetics
  • Receptors, Progesterone / metabolism*
  • Time Factors
  • Tumor Cells, Cultured
  • Up-Regulation

Substances

  • Receptors, Progesterone
  • progesterone receptor A
  • progesterone receptor B
  • Insulin-Like Growth Factor I